Medicine
Volume 35, Issue 9 , Pages 497-499 , September 2007

Secondary glomerular disease

References 

  1. Lai KS, Lai KN. Viral nephropathy. Nat Clin Pract Nephrol. 2006;2:254–262
  2. Kamar N, Rostaing L, Alric L. Treatment of hepatitis C-virus-related glomerulonephritis. Kidney Int. 2006;69:436–439
  3. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol. 2004 Mar–Apr;24:198–211
  4. Centers for Disease Control and Prevention (CDC) . Outbreaks of Escherichia coli O157:H7 associated with petting zoos–North Carolina, Florida, and Arizona, 2004 and 2005. Morb Mortal Wkly Rep. 2005;54:1277–1280
  5. Mallouk A, Pham PT, Pham PC. Concurrent FSGS and Hodgkin’s lymphoma: case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies. Clin Exp Nephrol. 2006;10:284–289
  6. Howse MLP, Bell GM. Drugs and toxins that damage the kidney. Medicine. 2007;35:399–403
  7. Meyrier A. Mechanisms of disease: focal segmental glomerulosclerosis. Nat Clin Pract Nephrol. 2005;1:44–54
  8. Lefaucheur C, Stengel B, Nochy D, et al. Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association. Kidney Int. 2006;70:1510–1517
  9. Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis. 2005;5:227–236

PII: S1357-3039(07)00181-8

doi: 10.1016/j.mpmed.2007.06.008

Medicine
Volume 35, Issue 9 , Pages 497-499 , September 2007

Article Tools